Many of the year’s top retina articles focused on age-related macular degeneration.
Read the top retina stories from 2022 below.
FDA approves Vabysmo for treatment of wet AMD, DME
Vabysmo (faricimab-svoa) from Genentech is an injectable eye medicine that works by targeting and inhibiting Ang-2 and VEGF-A pathways. Read more.
Insufficient treatment common among patients with wet AMD
NEW YORK — A large number of eyes with newly diagnosed wet age-related macular degeneration received insufficient treatment, leading to poor outcomes and vision loss. Read more.
Three patients with AMD